These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23146278)

  • 1. Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits.
    Yongxin S; Wenjun D; Qiang W; Yunqing S; Liming Z; Chunsheng W
    Ann Thorac Surg; 2013 Jan; 95(1):55-61. PubMed ID: 23146278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondhand smoking and matrix metalloproteinase-2 and -9 gene expression in saphenous veins of women nonsmokers.
    Sun Y; Lin Z; Ding WJ; Shi Y; Zhu L; Wei Q; Wang C
    Ann Thorac Surg; 2014 Aug; 98(2):556-62. PubMed ID: 24961841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated gene expression of extracellular matrix and adhesion molecules in saphenous vein conduits of hemodialysis patients.
    Sun Y; Ding W; Wei Q; Shen Z; Wang C
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):684-9. PubMed ID: 22264416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9.
    Chung AW; Rauniyar P; Luo H; Hsiang YN; van Breemen C; Okon EB
    J Vasc Surg; 2005 Oct; 42(4):747-56. PubMed ID: 16242564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.
    Berard X; Déglise S; Alonso F; Saucy F; Meda P; Bordenave L; Corpataux JM; Haefliger JA
    J Vasc Surg; 2013 May; 57(5):1371-82. PubMed ID: 23351647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentially positive ageing-related variations of medial smooth muscle cells in the saphenous veins used as aortocoronary bypass grafts.
    Perek B; Malinska A; Gasowski J; Ostalska-Nowicka D; Perek A; Jemielity M; Zabel M; Nowicki M
    Folia Histochem Cytobiol; 2016; 54(2):91-98. PubMed ID: 27845500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical handling of saphenous vein grafts induces expression of matrix metalloproteinase 9.
    Chen F; Eriksson P; Whatling C; Vaage J; Valen G
    Scand Cardiovasc J; 2008 Oct; 42(5):327-36. PubMed ID: 18609045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in gelatinase expression in the walls of vessels used as aortocoronary conduits may impact long-term graft patency.
    Perek B; Kowalska K; Nowicki M; Kempisty B; Puślecki M; Jankowski M; Jemielity M; Malińska A
    Kardiol Pol; 2019; 77(2):217-224. PubMed ID: 30676640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
    Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
    Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cardiovascular risk factors on levels of matrix metalloproteinases 2 and 9 in human abdominal aortic aneurysms.
    Dilmé JF; Bellmunt S; Camacho M; Solà-Villà D; Romero JM; Escudero JR; Vila L
    Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):374-81. PubMed ID: 24980077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
    Fiotti N; Altamura N; Orlando C; Simi L; Reimers B; Pascotto P; Zingone B; Pascotto A; Serio M; Guarnieri G; Giansante C
    Int J Cardiol; 2008 Jul; 127(3):350-7. PubMed ID: 17706812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure.
    Khaleel MS; Dorheim TA; Duryee MJ; Durbin HE; Bussey WD; Garvin RP; Klassen LW; Thiele GM; Anderson DR
    Ann Thorac Surg; 2012 Feb; 93(2):552-8. PubMed ID: 22206954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native matrix metalloproteinase characteristics may influence early stenosis of venous versus arterial coronary artery bypass grafting conduits.
    Anstadt MP; Franga DL; Portik-Dobos V; Pennathur A; Bannan M; Mawulawde K; Ergul A
    Chest; 2004 May; 125(5):1853-8. PubMed ID: 15136400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.